Literature DB >> 30065067

Insights into the Role of Mucosal Immunity in IgA Nephropathy.

Yue-Miao Zhang1,2,3,4, Hong Zhang5,2,3,4.   

Abstract

Entities:  

Keywords:  Glomerulonephritis, IGA; IgA nephropathy; Immunity, Mucosal; Immunoglobulin A; Mucosal immunity; Nefecon

Year:  2018        PMID： 30065067      PMCID： PMC6218814          DOI： 10.2215/CJN.04370418

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  Persistence of Autoreactive IgA-Secreting B Cells Despite Multiple Immunosuppressive Medications Including Rituximab.

Authors:  Yong He; Michiko Shimoda; Yoko Ono; Itzel Bustos Villalobos; Anupam Mitra; Thomas Konia; Sergei A Grando; John J Zone; Emanual Maverakis
Journal:  JAMA Dermatol       Date:  2015-06       Impact factor: 10.282

2.  A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction.

Authors:  Richard A Lafayette; Pietro A Canetta; Brad H Rovin; Gerald B Appel; Jan Novak; Karl A Nath; Sanjeev Sethi; James A Tumlin; Kshama Mehta; Marie Hogan; Stephen Erickson; Bruce A Julian; Nelson Leung; Felicity T Enders; Rhubell Brown; Barbora Knoppova; Stacy Hall; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2016-11-07       Impact factor: 10.121

3.  Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.

Authors:  Bengt C Fellström; Jonathan Barratt; Heather Cook; Rosanna Coppo; John Feehally; Johan W de Fijter; Jürgen Floege; Gerd Hetzel; Alan G Jardine; Francesco Locatelli; Bart D Maes; Alex Mercer; Fernanda Ortiz; Manuel Praga; Søren S Sørensen; Vladimir Tesar; Lucia Del Vecchio
Journal:  Lancet       Date:  2017-03-28       Impact factor: 79.321

Review 4.  The intestine-renal connection in IgA nephropathy.

Authors:  Rosanna Coppo
Journal:  Nephrol Dial Transplant       Date:  2014-11-11       Impact factor: 5.992

5.  Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow.

Authors:  Jessica L Halliley; Christopher M Tipton; Jane Liesveld; Alexander F Rosenberg; Jaime Darce; Ivan V Gregoretti; Lana Popova; Denise Kaminiski; Christopher F Fucile; Igor Albizua; Shuya Kyu; Kuang-Yueh Chiang; Kyle T Bradley; Richard Burack; Mark Slifka; Erika Hammarlund; Hao Wu; Liping Zhao; Edward E Walsh; Ann R Falsey; Troy D Randall; Wan Cheung Cheung; Iñaki Sanz; F Eun-Hyung Lee
Journal:  Immunity       Date:  2015-07-14       Impact factor: 31.745

6.  Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy.

Authors:  Qian Gong; Qinglin Ou; Shiming Ye; Wyne P Lee; Jennine Cornelius; Lauri Diehl; Wei Yu Lin; Zhilan Hu; Yanmei Lu; Yongmei Chen; Yan Wu; Y Gloria Meng; Peter Gribling; Zhonghua Lin; Kathy Nguyen; Thanhvien Tran; Yifan Zhang; Hugh Rosen; Flavius Martin; Andrew C Chan
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

7.  The gut-kidney axis in IgA nephropathy: role of microbiota and diet on genetic predisposition.

Authors:  Rosanna Coppo
Journal:  Pediatr Nephrol       Date:  2017-04-07       Impact factor: 3.714

8.  Steady-state generation of mucosal IgA+ plasmablasts is not abrogated by B-cell depletion therapy with rituximab.

Authors:  Henrik E Mei; Daniela Frölich; Claudia Giesecke; Christoph Loddenkemper; Karin Reiter; Stefanie Schmidt; Eugen Feist; Capucine Daridon; Hans-Peter Tony; Andreas Radbruch; Thomas Dörner
Journal:  Blood       Date:  2010-09-09       Impact factor: 22.113

9.  Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis.

Authors:  Keith Leiper; Kate Martin; Anthony Ellis; Sreedhar Subramanian; Alastair J Watson; Steve E Christmas; Deborah Howarth; Fiona Campbell; Jonathan M Rhodes
Journal:  Gut       Date:  2011-04-06       Impact factor: 23.059

10.  Effect of Continuous B Cell Depletion With Rituximab on Pathogenic Autoantibodies and Total IgG Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Authors:  Frank B Cortazar; William F Pendergraft; Julia Wenger; Charles T Owens; Karen Laliberte; John L Niles
Journal:  Arthritis Rheumatol       Date:  2017-03-31       Impact factor: 10.995
  10 in total
  9 in total

Review 1.  New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies.

Authors:  Dita Maixnerova; Delphine El Mehdi; Dana V Rizk; Hong Zhang; Vladimir Tesar
Journal:  J Clin Med       Date:  2022-05-16       Impact factor: 4.964

2.  Budesonide versus systemic corticosteroids in IgA Nephropathy: A retrospective, propensity-matched comparison.

Authors:  Gener Ismail; Bogdan Obrişcă; Roxana Jurubiţă; Andreea Andronesi; Bogdan Sorohan; Alexandra Vornicu; Ioanel Sinescu; Mihai Hârza
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.889

Review 3.  Progress in Pathogenesis of Immunoglobin A Nephropathy.

Authors:  Jemima C Stanley; Hong Deng
Journal:  Cureus       Date:  2020-06-23

4.  Helicobacter pylori infection is associated with elevated galactose-deficient IgA1 in IgA nephropathy.

Authors:  Xing-Zi Liu; Yue-Miao Zhang; Ni-Ya Jia; Hong Zhang
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

5.  Rifaximin as a Potential Treatment for IgA Nephropathy in a Humanized Mice Model.

Authors:  Vincenzo Di Leo; Patrick J Gleeson; Fabio Sallustio; Carine Bounaix; Jennifer Da Silva; Gesualdo Loreto; Sanae Ben Mkaddem; Renato C Monteiro
Journal:  J Pers Med       Date:  2021-04-16

6.  Identification of blood-based key biomarker and immune infiltration in Immunoglobulin A nephropathy by comprehensive bioinformatics analysis and a cohort validation.

Authors:  Jie Xu; Xiahong Shen; Xing Wei; Jie Ding; Jiaojiao Yuan; Zhen Weng; Yang He
Journal:  J Transl Med       Date:  2022-03-29       Impact factor: 5.531

Review 7.  Fermented natural product targeting gut microbiota regulate immunity and anti-inflammatory activity: A possible way to prevent COVID-19 in daily diet.

Authors:  Quancen Li; Na Li; Wenwen Cai; Meifang Xiao; Bin Liu; Feng Zeng
Journal:  J Funct Foods       Date:  2022-08-22       Impact factor: 5.223

Review 8.  Has The Time Arrived to Refine The Indications of Immunosuppressive Therapy and Prognosis in IgA Nephropathy?

Authors:  Bogdan Obrișcă; Ioanel Sinescu; Gener Ismail; Gabriel Mircescu
Journal:  J Clin Med       Date:  2019-10-02       Impact factor: 4.241

9.  A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy.

Authors:  Ruijuan Dong; Ming Bai; Jin Zhao; Di Wang; Xiaoxuan Ning; Shiren Sun
Journal:  Front Cell Infect Microbiol       Date:  2020-10-20       Impact factor: 5.293
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.